Elliott S. Fisher, MD, MPH is the Director of the Dartmouth Institute for Health Policy and Clinical Practice and the James W. Squires Professor of Medicine and Community and Family Medicine at the Geisel School of Medicine at Dartmouth. He is also Co-Director of the Dartmouth Atlas of Health Care. His early research focused on exploring the causes and consequences of the two fold differences in spending observed across U.S. regions. His more recent work focuses on evaluating the implementation and performance of Accountable Care Organizations - a payment and delivery reform now being implemented in the U.S. that he helped to develop. He has published broadly and is a member of the Institute of Medicine of the National Academy of Sciences.

Mark McClellan is senior fellow, director of the Engelberg Center for Health Care Reform, and Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution. Established in 2007, the Engelberg Center provides practical solutions to achieve high-quality, innovative, affordable health care with particular emphasis on identifying opportunities on the national, state and local levels.

A doctor and economist by training, McClellan has a highly distinguished record in public service and academic research. He is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the Food and Drug Administration. McClellan served as a member of the President's Council of Economic Advisers and senior director for health care policy at the White House under President George W. Bush. He also served in the Clinton administration as deputy assistant secretary of the Treasury for economic policy, where he supervised economic analysis and policy development on a range of domestic policy issues.

Previously, McClellan was an associate professor of economics and associate professor of medicine with tenure at Stanford University, where he directed Stanford's Program on Health Outcomes Research; served as associate editor of the Journal of Health Economics; and was co-principal investigator of the Health and Retirement Study, a longitudinal study of the health and economic status of older Americans.

McClellan holds an MD from the Harvard University-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, a PhD in economics from MIT, an MPA from Harvard University, and a BA from the University of Texas at Austin.

Sean Cavanaugh is the Deputy Administrator and Director of the Center for Medicare at the Centers for Medicare & Medicaid Services. He is responsible for overseeing the regulation and payment of Medicare fee-for service providers, privately-administered Medicare health plans, and the Medicare prescription drug program. Medicare provides health coverage to 50 million elderly and disabled Americans, with an annual budget of over $550 billion.

Prior to assuming his current role, Sean was the Deputy Director for Programs and Policy in the Center for Medicare and Medicaid Innovation. In that capacity, he was responsible for overseeing the development and testing of new payment and service delivery models, including accountable care organizations and medical homes.

He attended the University of Pennsylvania and the Johns Hopkins School of Hygiene and Public Health.

Dr. Sam Ho is currently Chief Medical Officer for UnitedHealthcare, UnitedHealth Group's health benefits division, and, as President of Clinical Shared Services, is responsible for the clinical advancement of 38 million members throughout the U.S., including enrollees in commercial, Medicare, Medicaid, and military health plans. He is the clinical executive specifically responsible for the execution of the quality improvement, medical management, care delivery transformation, performance measurement, transparency, and health care affordability programs throughout UnitedHealthcare and is also active in helping lead the value-based benefits and value-based provider payment programs.

Dr. Samuel Nussbaum is Executive Vice President, Clinical Health Policy, and Chief Medical Officer for WellPoint, Inc. He is the key spokesperson and policy advocate for WellPoint. He oversees corporate medical and pharmacy policy to ensure the provision of clinically proven effective care. Dr. Nussbaum collaborates with industry leaders, physicians, hospitals and national policy and health care organizations to shape an agenda for quality, safety and clinical outcomes and to improve patient care for WellPoint's 34 million medical members nationwide.

Dr. Nussbaum currently serves on the Boards of the National Quality Forum (NQF), the OASIS Institute, and BioCrossroads, Dr. Nussbaum is a Professor of Clinical Medicine at Washington University School of Medicine and serves as adjunct professor at the Olin School of Business, Washington University.

Joseph M. Zubretsky is Senior Executive Vice President of Aetna's National Businesses and a member of the company's Executive Committee, its senior governing body. He also directs Aetna's corporate strategy and corporate development.

Mr. Zubretsky leads several major business areas at Aetna, including National Accounts, which serves domestic and multi-national corporations; HealthagenSM, which delivers population health and technology services; National Network Contracting and Care Management; Workers Compensation; and Aetna's specialty products, including Aetna Behavioral Health, Aetna Pharmacy Management, Payflex, and Prodigy Health Group.

Mr. Zubretsky previously served for six years as Aetna's Chief Financial Officer. He has more than 30 years of experience as a senior executive, including at Unum Group and MassMutual Financial Group.

Mark McClellan is senior fellow, director of the Engelberg Center for Health Care Reform, and Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution. Established in 2007, the Engelberg Center provides practical solutions to achieve high-quality, innovative, affordable health care with particular emphasis on identifying opportunities on the national, state and local levels.

A doctor and economist by training, McClellan has a highly distinguished record in public service and academic research. He is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the Food and Drug Administration. McClellan served as a member of the President's Council of Economic Advisers and senior director for health care policy at the White House under President George W. Bush. He also served in the Clinton administration as deputy assistant secretary of the Treasury for economic policy, where he supervised economic analysis and policy development on a range of domestic policy issues.

Previously, McClellan was an associate professor of economics and associate professor of medicine with tenure at Stanford University, where he directed Stanford's Program on Health Outcomes Research; served as associate editor of the Journal of Health Economics; and was co-principal investigator of the Health and Retirement Study, a longitudinal study of the health and economic status of older Americans.

McClellan holds an MD from the Harvard University-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, a PhD in economics from MIT, an MPA from Harvard University, and a BA from the University of Texas at Austin.

Tom Valuck joined Discern Health in October 2013, bringing the firm national leadership experience in quality and performance-based payment from his positions at the Centers for Medicare & Medicaid Services (CMS) and the National Quality Forum (NQF). He helps private and public sector clients who are transforming the health care system on the front lines to achieve better health and healthcare outcomes at lower cost.

Tom joined Discern after four years at NQF, where he was Senior Vice President for Strategic Partnerships. In that role, he oversaw the NQF-convened partnerships—the Measure Applications Partnership (MAP) and the National Priorities Partnership (NPP)—as well as NQF's engagement with states and regional community alliances. These NQF initiatives promote the use of performance measurement information for public reporting, payment incentives, accreditation and certification, and systems improvement.

Mary Barton, MD is Vice President for Performance Measurement at NCQA. Dr. Barton oversees the team supporting new quality measure development and the upkeep of existing measures in the HEDIS measure set. She also leads selected grants and contracts that focus on NCQA's strength as a measure developer and an experienced evaluator of health care. She is a member of NCQA's Leadership Team. Prior to coming to NCQA, Dr. Barton was for over five years Scientific Director of the U.S. Preventive Services Task Force (USPSTF) at the Agency for Healthcare Research and Quality (AHRQ). Dr. Barton trained in primary care internal medicine at Brigham and Women's Hospital in Boston, and completed a general medicine research fellowship at Harvard. Prior to joining AHRQ, she was an assistant professor at Harvard Medical School, where she performed clinical epidemiology and health services research related to cancer screening and prevention in terms of access, test performance, and outcomes. She is a member of the American College of Physicians and the Society of General Internal Medicine. Dr. Barton received her MD from Harvard University and a master's in public policy from the Kennedy School of Government at Harvard.

Steven J. Bernstein earned his MD from the University of Rochester, completed his residency at the University of Pittsburgh, and received his MPH from the UCLA. He is a Professor of Medicine and Associate Dean (Clinical Affairs) at the University of Michigan where he directs Quality for the Faculty Group Practice. He is responsible for measuring and improving ambulatory quality, developing chronic disease registries and working with pay-for-performance programs such as the Medicare Shared Saving Program. He is also an attending physician at the Ann Arbor VA Medical Center and a Research Scientist at the Center for Clinical Management Research.

Jen Clair is the Staff Vice President of Advanced Analytics at WellPoint and has responsibility for Clinical Analytics in support of Provider, Care Management and Premium Risk Adjustment programs. Currently, her team supports many aspects of provider payment innovation; including provider reporting, performance measurement and process monitoring. She has over ten years of experience developing predictive risk targeting models, supporting clinical program design, and evaluation. Prior to this, she was a State Epidemiologist for the Virginia Department of Health, where she supported the development and deployment of disease surveillance systems. Jen has a Master's in Public Health, with a concentration in Biostatistics, from Virginia Commonwealth University.

Scott Hines, MD is Crystal Run Healthcare's Co-Chief Clinical Transformation Officer and physician leader for Crystal Run Healthcare's medical specialties division which includes Endocrinology, Nephrology, Dermatology, Rheumatology, Infectious Disease, Pain Management and Physical Rehabilitation. Dr. Hines is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism. In 2006, Dr. Hines joined Crystal Run Healthcare. In his role as Co-Chief Clinical Transformation Officer, Hines helps to develop and implement the clinical programs necessary to deliver value based care. These include the development of best practice guidelines, a variation reduction program, and various quality improvement initiatives. Dr. Hines is also a physician reviewers for the National Committee for Quality Assurance's (NCQA) patient centered medical home program (PCMH).

Hoangmai Pham is a general internist and Director of the Seamless Care Models Group at the CMS Innovation Center, where she is responsible for overseeing portfolios of demonstrations on accountable care organizations and advanced primary care. SCMG sponsors the Pioneer ACO Model, the Advance Payment Model, the Comprehensive Primary Care Initiative, and the Comprehensive ESRD Care Initiative, and continues to develop new models. Prior to coming to CMS, Dr. Pham was senior researcher and co-director of research at the Center for Studying Health System Change and Mathematica. She has published extensively on care fragmentation and coordination, provider market trends, health disparities, primary care, and quality measurement/improvement, and the intersection of each of these with provider payment policy. Dr. Pham also contributed tot he design of Medicare demonstrations and programs, including the Physician Quality Reporting System and Resource Use Reports. She practiced for many years at safety net clinics in the Washington area. Dr. Pham received her AB from Harvard, her MD from Temple University, and her MPH from Johns Hopkins, where she was also a Robert Wood Johnson Clinical Scholar.

H. Scott Sarran, M.D., is Divisional Senior Vice President and Chief Medical Officer, Government Programs, Health Care Service Corporation (HCSC). He is responsible for network strategy and oversight (including ACOs), medical management and quality for HCSC's government programs in all five (IL, TX, NM, OK, MT) states. Dr. Sarran joined HCSC in 2008 as Chief Medical Officer for Blue Cross Blue Shield of Illinois.

Jim Fawcett is senior vice president of provider contracting and has been with Highmark for over 25 years. Mr. Fawcett's most recent responsibilities include the contracting and servicing with health care providers to provide Highmark members with access to high-quality and affordable health care. Mr. Fawcett's teams also lead the transformation from traditional fee for service contracts to new pay for value contracts that include Accountable Care Organizations, Patient Centered Medical Homes and other pay for value efforts. Provider contracting staff also develop strategies to use technology to better service our provider partners to ultimately benefit both health care professionals and Highmark members.

He started in private practice in Salem, Massachusetts, and has held a teaching position through Harvard University, Brown University and Michigan State University Medical Schools. Dr. Raskauskas left academics in 2008 to become Medical Director in Dearborn, Michigan, overseeing a multi-specialty, multi-site clinic. After working with the a health system in Dearborn, Michigan to develop an accountable care organization, he took on the position of Chief Medical Officer of Meridian Health Plan, a Medicaid HMO in 5 states.

Dr. Raskauskas is now CEO/President of St. Vincent's Health Partners (SVHP St. Vincent's Health Partners (SVHP) is the first URAC accredited Clinically Integrated Network in the country.

Dr. Dick Salmon is responsible for Cigna's programs that evaluate physician and hospital cost and quality and for using that information to help consumers make informed decisions about where to seek care, and also to incentivize physicians and hospitals to improve care. In particular he is responsible for Cigna's Collaborative Accountable Care program, which enables and rewards achievement of improved quality, cost and satisfaction with care. He is also responsible for Cigna's quality program and accreditation initiatives, and components of Cigna's population health measurement and improvement initiatives. Dr. Salmon previously held several other positions at Cigna, including clinical development of new care facilitation programs in case management and disease management, regional medical director for New England, and president and general manager of Cigna HealthCare of New Hampshire. Before joining Cigna, Dr. Salmon was senior vice president and chief medical officer for the HMO HealthSource, which Cigna acquired in 1997. Dr. Salmon has worked extensively in managed care since 1984. He began his career in academic medicine at Case Western Reserve University and its affiliated University Hospital, where he was assistant professor of family medicine and chief resident in family practice. Dr. Salmon is board-certified in family practice and earned his medical degree and a Ph.D. in biomedical engineering from Case Western Reserve University. He holds a Bachelor of Science degree in engineering and a Bachelor of Arts degree from Princeton University.

Dr, McGeeney serves as a visiting scholar to the Brookings Institution and as the Chief Medical Officer for Village MD. Prior to his current position, Dr McGeeney was a Director for BDC Advisors and prior to that the founder/CEO of TransforMED, a subsidiary of the American Academy of Family Physicians. Dr McGeeney is Board Certified in Family medicine and practiced for almost 30 years in both a rural solo practice and as medical director of a large physician owned multi-specialty group. Dr McGeeney holds an MBA in Healthcare Administration from the University of Colorado.

Louis S. Bezich is Chief of Staff to the President and CEO of the Cooper Health System and also serves as Executive Director of Cooper's Center for Population Health. He leads a number of system-wide initiatives including development of Cooper's accountable care business model and represents Cooper on the board of the Camden Coalition of Health Care Providers.

Bezich serves as Vice Chair of the Rowan University-Rutgers Camden Board of Governors, an organization focused on generating collaborative instruction and research in the health sciences. Since 2002 he has served as Chairman of the Camden Higher Education and Health Care Task Force.

Michael Lachenmayer is Director of Strategic Alliances at AmeriHealth Administrators, a third-party administrator and subsidiary of Independence Blue Cross, where he leads the ACO and BPO strategy teams. Mr. Lachenmayer has over twenty years' experience in diverse sectors of the health care industry, including health systems, health care software companies, and payers.

Mr. Lachenmayer received his M.S. in Health Care Delivery from Dartmouth College/Tuck School of Business.

Corbin Petro is President of ElevateHealth Solutions, a joint venture between Harvard Pilgrim, Dartmouth Hitchcock, and Elliot Health System advancing value-based care and payment innovation. Petro leads strategic direction and operations for the organization.

Previously, Petro was the Chief Operating Officer of the Massachusetts Department of Medicaid (MassHealth) where she oversaw operations for the $13B agency and led initiatives such as predictive modeling and new payment and care delivery models. Petro has an extensive background in healthcare including advising a US Senator on health reform, and roles at Bain and Company, Goldman Sachs, Deloitte Consulting and American Management Systems.

Petro received a BA from Yale University and an MBA from the Wharton School at the University of Pennsylvania.

Miles Snowden is a strategic advisor and innovator for providers and payers seeking successful development and participation in new business models.

As the senior physician executive for Optum, the health services division of UnitedHealth Group, Snowden provides clinical oversight of the company's development and distribution of health care technology, services and consulting designed to assist Optum's provider and payer clients in making informed health care decisions, preventing illness, gaining operational efficiency and maximizing financial performance. Optum serves more than 250,000 providers, more than 350 payers and nearly 60 million health care consumers.

Alice M. Rivlin is the Director of the Engelberg Center for Health Care Reform, the Leonard D. Schaeffer Chair in Health Policy Studies and a Senior Fellow in Economic Studies at the Brookings Institution. She is also a Visiting Professor at the Public Policy Institute of Georgetown University. In 2010 President Obama appointed Rivlin to the Simpson-Bowles Commission on the federal budget. She also co-chaired, with former Senator Pete Domenici, the Bipartisan Policy Center's Debt Reduction Task Force. An expert on fiscal and monetary policy, social policy, and urban issues, Rivlin served as the vice chair of the Federal Reserve Board from 1996 to 1999. She was director of the White House Office of Management and Budget from 1994 to 1996, helping to transform a large budget deficit into substantial surpluses by the end of the decade. She founded the Congressional Budget Office (CBO) in 1975 and served as its director until 1983, creating an independent agency that continues to provide high-quality, nonpartisan analysis to Congress as it works on spending and revenue legislation.

Rivlin is the author of numerous books and articles, among them Systematic Thinking for Social Action and Restoring the American Dream. In 2008, Rivlin received the inaugural Daniel Patrick Moynihan Prize from The AAPSS. Rivlin has received a MacArthur Foundation Prize Fellowship, and has taught at Harvard, George Mason, and New School Universities.

Leonard Schaeffer was the founding Chairman & CEO of WellPoint, Inc. and was President & CEO of Blue Cross of California. He is currently a Senior Advisor to TPG Capital and is the Judge Widney Chair and Professor at the University of Southern California. In Federal government, he served as Assistant Secretary for Management and Budget of HHS and Administrator of HCFA (now CMS). He serves on many boards, including Quintiles, Brookings, RAND, USC, Brewster Foundation and the Board of Fellows at Harvard Medical School. He chairs the advisory board for USC's Schaeffer Center for Health Policy & Economics.

Mr. Scully joined WCAS in 2004 as a Senior Operating Executive and became a General Partner in 2006. Mr. Scully focuses on investments in the healthcare industry. Prior to joining WCAS, he was the Administrator of the Centers for Medicare and Medicaid Services (CMS) for three years and the President and CEO of the Federation of American Hospitals for six years. He also served as the Deputy Assistant to the President and as the Associate Director of OMB under President GHW Bush from 1989 to 1993, and has practiced law at Alston and Bird; Patton Boggs; and Akin, Gump, Strauss Hauer and Feld. Mr. Scully received a B.A. from the University of Virginia in 1979 and a J.D. from Catholic University in 1986.

Dr. Farzad Mostashari is a visiting fellow of the Engelberg Center for Health Care Reform at the Brookings Institution. Dr. Mostashari's work covers a range of topics related to helping clinicians improve care and patient health through health IT, focusing on small practice transformation by developing innovative payment models that can better support these types of practices. This work will include expanding the reach of the Accountable Care Organization (ACO) Learning Network, a Brookings-Dartmouth project that provides participating organizations the tools necessary to successfully implement accountable care.

Chief Medical Officer, Robert W. Brenner, MD, MMM, oversees and implements strategic growth and continuous improvement of care for individuals and populations, while ensuring the appropriate cost of care at Summit Medical Group. He is leading change for the largest for-profit, physician-owned multispecialty practice in New Jersey.

A healthcare innovator, Dr. Brenner has developed unique Care Management, Transition of Care, and Population Health programs as well as several nationally recognized clinical centers of excellence. As a recognized spokesperson on many topics in healthcare, he has appeared on regional and national television, at national conferences, and before the New Jersey State Assembly Healthcare Committee. Dr. Brenner was a lead hospital administrator, Executive Team member, Chairman of Family Medicine, and Residency Director at Atlantic Health before joining Summit Medical Group.

With a passion for innovations in healthcare, Jeff has played different roles as an entrepreneur and senior executive in the industry. Prior to creating Privia Health, he was Founder and CEO of BroadReach Healthcare, a company focused on creating large-scale health delivery networks in emerging markets. Jeff led BroadReach to become a widely recognized global health company. Prior to BroadReach, Jeff also served as Director at The Advisory Board Company- a healthcare technology and consulting firm representing over 2,500 health organizations. Jeff has also served as COO and interim CEO for two hospitals. He is a frequent speaker on innovations in the healthcare industry.

NEIL CALMAN, M.D., is a Board Certified family physician who has been practicing in the Bronx and Manhattan for the past 35 years. He is President and a co-founder of the Institute for Family Health and Chairman of Family Medicine and Community Health at the Mount Sinai School of Medicine and the Mount Sinai Medical Center. Since 1983 Dr. Caiman has led the Institute in developing family health centers in the Bronx, Manhattan and the Hudson Valley and in establishing health pmfessional training in medicine, nursing, administration and mental health. Dr. calman sits on many Federal and State advisory bodies including the Federal HIT Policy Committee where he serves on the Meaningful Use Subcommittee. He is the recipient of numerous awards and author of many published papers.

Al Kurose, M.D., MBA, FACP has served as CEO of Coastal Medical since 2008. Coastal provides care to 120,000 patients in twenty medical offices across Rhode Island. Kurose has been a driving force behind Coastal's transition to accountable care, and is an active leader in the Rhode Island healthcare community.

Dr. Kurose is a graduate of the Washington University School of Medicine in St. Louis, the Brown University Internal Medicine Residency Training Program, and the Yale School of Management. He was a founder of Coastal Medical and practiced internal medicine for 20 years.

Dr. Hymin Zucker is Chief Medical Officer for Triple Aim Advisory Group, a team of healthcare executives with over 100 years of expertise offering a full range of operational and management services to Accountable Care Organizations (ACO), Physicians groups, and Skilled Nursing Facilities nationwide. Dr. Zucker, a practicing internal medicine physician for more than twenty years, is one of the nation's leading authorities and innovators on physician protocols, providing quality experiences to patient care while reducing unnecessary costs. Dr. Zucker recently served as the founding Chief Medical Officer for a 32,000 Medicare Beneficiary physician-owned, and funded ACO in Florida. This ACO had greater than 100 participating primary care and 95 specialty physicians, and was a top performing ACO earning a Medicare Shared Savings Program payment in 2013 of $33Million.

Dr. Zucker has successfully implemented primary care models for Provider Service Networks, a Medicare Advantage risk population of 60,000 patients. In 2009, his organization was recognized as the first NCQA Patient-Centered Medical Home certified in Florida. He also organized 70 Primary Care Providers, serving an additional 20,000 patients under the MSO.

Dr. Zucker has established Medicare Advantage Plans, contracting with 120 PCP's and over 100 specialists throughout Florida. In addition, he has successfully developed Primary Care and Specialist Networks to meet Medicare Advantage Plan (MAP) application requests and obtained licensure.

Dr. Zucker's knowledge has established ground-breaking physician performance evaluation models which measure efficiency, quality and continual improvements to healthcare including the development and training program on accurate submissions of ICD-9 codes. His pay-for-performance program measures physician performance, patient satisfaction, and on-going communication programs aimed at ensuring the delivery of the right care to the right patient at the right time.

Dr. Zucker is a founding member of Florida Association of ACO's (FLAACO), a member of the Centers for Medicare and Medicaid Services (CMS) and a member of the Brookings Institution's ACO Learning Network, where he is involved in the physician-led ACO Innovation Exchange.

Dr. Zucker has a bachelor's of science degree from Stony Brook College, New York, a Master's Degree in Nutrition from the University of Nebraska, Lincoln, and a Doctorate in Medicine from New York Medical College. He completed his residency in Internal Medicine at Lenox Hill Hospital, New York. He holds certifications from the American Board of Internal Medicine, the American Board of Managed Care Physicians, and the American Board of Quality Assurance and Utilization Review Physicians.

Dr. James Colbert is a member of the Brigham and Women's Hospital Division of Medical Communications as well as a faculty member at Harvard Medical School and at Ariadne Labs. Dr. Colbert practices general internal medicine as a hospitalist at Newton-Wellesley Hospital in Newton, Massachusetts. Dr. Colbert is a scholar in the Harvard Macy Institute 2014 Program for Educators in the Health Professions and is currently working with the Brookings Institution on their physician-led ACO Innovation Exchanges. Prior to his work with the Brookings Institution, he was an editorial fellow at the New England Journal of Medicine.

Timothy G. Ferris, MD, MPH, is a practicing general internist, and SVP for Population Health at Mass General Hospital and Partners HealthCare in Boston. He is also an Associate Professor of Medicine and Pediatrics at Harvard Medical School. He holds degrees from Middlebury College, Oxford University, Harvard Medical School, and the Harvard School of Public Health. Dr. Ferris has over 90 publications in the areas of healthcare quality measurement, risk adjustment, population management, and information technology. He leads the Partners Healthcare ACO. He has served on multiple committees for Agency for Healthcare Research and Quality, and National Quality Forum. He has served as a consultant to the Congressional Research Service, National Governor's Association, the World Health Organization, the Institute for Healthcare Improvement, and the Institute of Medicine.

Michael is president of the Informed Medical Decisions Foundation. In 2014, the Foundation became a division of Healthwise, another mission-driven nonprofit. Michael is now also the Chief Science Officer at Healthwise. Healthwise's mission is to help people make better health decisions. He is a past president of the Society for Medical Decision Making (SMDM) and the Society of General Internal Medicine in the United States. Michael has led many prominent research studies including the Patient Outcome Research Team for Prostatic Diseases. Michael continues to practice primary care and serves as medical director of the John D. Stoeckle Center for Primary Care Innovation at MGH. He is also a clinical professor of medicine at Harvard Medical School and a Master of the American College of Physicians.

Jessica Greene, Ph.D. is a Professor in the George Washington University School of Nursing, where she is also the Associate Dean for Research. Dr. Greene is a health services researcher who evaluates health policies intended to improve health care quality. Specifically, she investigates the role of patients in influencing health outcomes and understanding health care choices. She also examines the impact of financial incentives on consumers and health care providers. Her research has been published widely, including in Health Affairs, Journal of General Internal Medicine, and the Milbank Quarterly. She holds a PhD from New York University.

N. Lee Rucker's decades of front-line health policy experience were honed on staff with diverse transformation leaders: American Medical Group Association, the pharmaceutical industry, American Pharmacists Association; plus a decade with the National Council on Patient Information and Education (NCPIE). From 2004-2013, Rucker was a Medicare Part D expert at the AARP Public Policy Institute. This year's honors include an American Pharmacists Association award for her decades of patient advocacy; and selection for the 2014 Health Datapalooza Consumers' Circle. Rucker now serves as NCPIE's Senior Advisor; and is Principal of policy consultancy, EnhanceValue.info. Rucker is a graduate of The University of Michigan; and the University of North Carolina, School of Public Health.

Deborah Feinstein serves as Director of the Bureau of Competition at the Federal Trade Commission (FTC) in Washington, DC. Previously she had been a partner at Arnold & Porter LLP, where she was head of the U.S. Antitrust practice group and specialized in representing clients before the FTC and DOJ. From 1989 to 1991, she worked at the FTC as the Assistant to the Director of the Bureau of Competition and as an attorney adviser to former Commissioner Dennis A. Yao. She is a 1983 graduate of the University of California, Berkeley and a 1987 graduate of Harvard Law School. Global Competition Review named her in 2011 as its inaugural Competition Lawyer of the Year.

Paul Ginsburg is Norman Topping Chair in Medicine and Public Policy at the University of Southern California. Continuing to be based in the Washington, DC area, he teaches graduate health administration courses and conducts health policy research. From 1995 through the end of 2013 he was President of the Center for Studying Health System Change (HSC). Prior to his founding HSC, Ginsburg served as the founding Executive Director of the Physician Payment Review Commission (now the Medicare Payment Advisory Commission). Ginsburg was a Senior Economist at RAND and served as Deputy Assistant Director at the Congressional Budget Office (CBO).

Robert A. Berenson, M.D. is an Institute Fellow at the Urban Institute in Washington, D.C. He has published widely on a range of topics, including physician payment reform, Medicare private plan contracting, and provider and plan pricing power. He was a senior official in two Administrations and recently completed a term as a Commissioner at MedPAC, the last two years as Vice-Chair. A graduate of the Mount Sinai School of Medicine, Dr. Berenson is a board-certified internist who practiced for over 20 years. He is a Fellow of the American College of Physicians.

Toby Singer is one of the nation's leading authorities on mergers and other antitrust matters in the health care industry, and her practice focuses on antitrust counseling and litigation for health care clients. She represents providers and payers on a wide variety of antitrust issues, from mergers and acquisitions and other transactions to less formal alliances among competitors as well as counseling on conduct issues. She has handled numerous federal and state government investigations and has defended clients in both government and private antitrust litigation.

Toby is a member of the Board of Directors of the American Health Lawyers Association as well as a past chair of the AHLA Antitrust Practice Group. She has served as a vice chair of the Health Care Committee of the American Bar Association Section of Antitrust Law, and has been on the advisory board of BNA's Health Law Reporter.